BOLD
Boundless Bio, Inc.
2.80$
+0.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -4.59 | -3.18 | -2.45 | -1.05 | -1.78 | -2.11 | -3.58 | -2.09 | |
| 0.15 | 0.14 | 0.17 | 0.03 | 0.04 | 0.04 | 0.06 | 0.06 | |
| 0.19 | 0.26 | 0.37 | 0.05 | 0.10 | 0.15 | 0.44 | 0.27 | |
| 8.92 | 0.88 | 6.28 | -0.04 | 0.04 | -0.04 | -0.10 | 0.15 | |
| 1.56 | 0.28 | 0.26 | 0.09 | 0.05 | 0.03 | 0.15 | 0.02 | |
| -5.81 | -1.26 | -4.20 | -2.67 | 0.73 | -1.72 | -1.54 | 1.69 | |
| -3.41 | -1.47 | -3.28 | – | – | – | 0.01 | 0.01 | |
| 7.06 | 4.54 | 9.05 | 4.75 | 0.01 | 4.40 | 5.29 | 0.01 | |
| -3.34 | 0.10 | 2.39 | 1.03 | -1.05 | 0.57 | 0.17 | -0.39 | |
| -6.15 | -3.46 | -2.72 | -1.14 | -1.83 | -2.14 | -3.73 | -2.11 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.